Lenacapavir

Latest

A health official holds Lenacapavir, a long‑acting HIV prevention treatment, in Epworth outside the capital Harare, Zimbabwe, February 19, 2026.REUTERS/Philimon Bulawayo

Lenacapavir: the HIV Breakthrough Proving Why NIH Funding Matters

by

Biomedical advances such as lenacapavir depend on years of publicly funded basic research

HIV patients chat at Nkosi's Haven, in south of Johannesburg, South Africa, on November 28, 2014.

How AI "Besties" in South Africa Are Changing Uptake of HIV Medication

by ,

Chatbot companions, such as Aimee, are part of a broad wave of digital health tools being tested across HIV programs

Lenacapavir Can Transform HIV Prevention—If Countries Support Access

by

By 2030, nearly 60% of global PrEP demand will be concentrated in historically underserved communities

A person who contracted HIV after losing access to PrEP, washes his face, in Asaba, Delta State, Nigeria, on May 31, 2025.